More good news about the twice-yearly PrEP injection - Queerty
Lenacapavir, a new injectable PrEP, shows promising effectiveness in trials, particularly for populations previously underserved by existing medications.
Gamechanger' HIV prevention drug to be made available cheaply in 120 countries
Gilead has agreed to make lenacapavir available cheaply in 120 countries, but many high-HIV burden nations are excluded, creating access issues.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
Stunning trial shows twice-yearly shots can prevent HIV infection
Injections of lenacapavir prevented HIV infection among women in Africa.
Experts say a twice-yearly injection that offers 100 percent protection against HIV is 'stunning'
Twice-yearly shots for AIDS were 100 percent effective in preventing infections in women, with high potential for broader use as a preventative measure.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ Nation
Lenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
More good news about the twice-yearly PrEP injection - Queerty
Lenacapavir, a new injectable PrEP, shows promising effectiveness in trials, particularly for populations previously underserved by existing medications.
Gamechanger' HIV prevention drug to be made available cheaply in 120 countries
Gilead has agreed to make lenacapavir available cheaply in 120 countries, but many high-HIV burden nations are excluded, creating access issues.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
Stunning trial shows twice-yearly shots can prevent HIV infection
Injections of lenacapavir prevented HIV infection among women in Africa.
Experts say a twice-yearly injection that offers 100 percent protection against HIV is 'stunning'
Twice-yearly shots for AIDS were 100 percent effective in preventing infections in women, with high potential for broader use as a preventative measure.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ Nation
Lenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
Beginning of end of HIV epidemic? - Harvard Gazette
Researchers are cautiously optimistic about a new preventative treatment for the AIDS virus, lenacapavir, showing promising results in preventing infection.